TLSA Insider Trading Activity

Transactions disclosed by company insiders to the SEC on Form 4, most recent first.

InsiderRoleDateSharesValue
Elrifi Ivor Chief Executive Officer 2026-08-05 237,616 $237,616
Elrifi Ivor Chief Executive Officer 2026-08-04 83,807 $81,293
Elrifi Ivor Chief Executive Officer 2026-08-03 667,000 $667,000
CERRONE GABRIELE M Director 2026-07-21 42,357 $41,933

How Institutional Funds Moved on TLSA

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
Dauntless Investment Group, LLC Dauntless Investment Group, LLC reduced this position by 41% ($2,533,320 -> $1,487,360). 2026-06-30

Which Funds Hold TLSA

Largest reported positions as of 2026-06-30.

FundValueShares
Dauntless Investment Group, LLC $1,487,360 1,162,000
GOLDMAN SACHS GROUP INC $152,625 119,238
CITADEL ADVISORS LLC $102,684 80,222
Focus Partners Wealth $101,587 79,365
GEODE CAPITAL MANAGEMENT, LLC $100,101 78,204
HSBC HOLDINGS PLC $78,046 62,437
UBS Group AG $76,833 60,026
SUSQUEHANNA INTERNATIONAL GROUP, LLP $71,552 55,900
SIMPLEX TRADING, LLC $66,048 51,600
Private Advisor Group, LLC $25,146 19,645

Data compiled from public SEC filings. This is informational reporting, not investment advice.

TLSA CEO Buys $237K in Shares Amid $986K Insider Cluster Buy

Stock chart and SEC Form 4 filing document representing insider stock purchase disclosure for Tiziana Life Sciences

Tiziana Life Sciences Ltd (NASDAQ: TLSA) disclosed a fresh insider purchase this week, with Chief Executive Officer Elrifi Ivor buying 237,616 shares on the open market on August 5, 2026, at a price of $1.00 per share. The transaction, recorded on a Form 4 filing with the SEC, totals $237,616.00 and was paid for with … Read more